| Price | 135.50p on 04-12-2025 at 19:40:05 |
|---|---|
| Change | -0.50p -0.37% |
| Buy | 136.00p |
| Sell | 135.00p |
| Last Trade: | Unknown 2,439.00 at 135.50p |
| Day's Volume: | 259,331 |
| Last Close: | 135.50p |
| Open: | 136.00p |
| ISIN: | GB00BJQTGV64 |
| Day's Range | 135.50p - 136.00p |
| 52wk Range: | 107.50p - 168.00p |
| Market Capitalisation: | £114.67m |
| VWAP: | 135.25468p |
| Shares in Issue: | 84.62m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Diaceutics (DXRX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 2,439 | 135.50p | Ordinary |
15:55:09 - 04-Dec-25 |
| Unknown* | 25,000 | 135.50p | Ordinary |
15:29:20 - 04-Dec-25 |
| Unknown* | 25,000 | 135.00p | Ordinary |
15:27:16 - 04-Dec-25 |
| Sell* | 12,000 | 135.00p | Ordinary |
15:26:30 - 04-Dec-25 |
| Unknown* | 25,000 | 135.50p | Ordinary |
15:15:40 - 04-Dec-25 |
| Sell* | 11,573 | 135.10p | Ordinary |
15:10:37 - 04-Dec-25 |
| Buy* | 1,000 | 136.00p | Ordinary |
14:50:31 - 04-Dec-25 |
| Unknown* | 1,000 | 136.00p | OTC Trade |
14:50:31 - 04-Dec-25 |
| Unknown* | 50,000 | 135.50p | Negotiated Trade |
14:42:32 - 04-Dec-25 |
| Unknown* | 60,000 | 135.00p | Negotiated Trade |
14:36:50 - 04-Dec-25 |
Diaceutics (DXRX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Nov 2025 11:53 am | RNS | PDMR Shareholding/SIP & Total Voting Rights |
| 4th Nov 2025 7:00 am | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
| 7th Oct 2025 7:00 am | RNS | Block listing Interim Review |
| 1st Oct 2025 11:40 am | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
| 23rd Sep 2025 7:00 am | RNS | H1 2025 Results |
| 11th Sep 2025 7:00 am | RNS | Notice of Results |
| 9th Sep 2025 10:47 am | RNS | Holding(s) in Company |
| 2nd Sep 2025 7:00 am | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
| 11th Aug 2025 10:58 am | RNS | Holding(s) in Company |
| 5th Aug 2025 7:00 am | RNS-R | Diaceutics at Canaccord Genuity Growth Conference |
